巨噬细胞极化与良性前列腺增生的关系研究进展
摘要
关键词
全文:
PDF参考
Nicholson, T. M&Ricke, W. A. Androgens and estrogens in benign prostatic hyperplasia: past, present and future[J].Differentiation 82, 2011(8):184-199.
Coyne KS, et al. Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS[J].BJU Int,2009(103):24-32
CHENG W, CHENG M, LIHONG G, et al. Macrophage Polarization and Its Role in Liver Disease[J]. FRONT IMMUNOL, 2021(12):803037.
Abo-Youssef AM, Afify H, Azouz AA, et al. Febuxostat attenuates testosterone-induced benign prostatic hyperplasia in rats via inhibiting JAK/STAT axis[J].Life Sci,2020(260):118414.
Lim S, Kim HK, Lee W, et al. Botanical preparation HX109 inhibits macrophage-mediated activation of prostate epithelial cells through the CCL4-STAT3 pathway: implication for the mechanism underlying HX109 suppression of prostate hyperplasia[J].Heliyon,2020(6):4267.
Wang L, Li Y, Wang X, et al. GDF3 Protects Mice against Sepsis-Induced Cardiac Dysfunction and Mortality by Suppression of Macrophage Pro-Inflammatory Phenotype[J].Cells,2020 (1):120.
Lu H, Wu L, Liu L, et al. Quercetin ameliorates kidney injury and fibrosis by modulating M1/M2 macrophage polarization[J].Bioche mPharmacol,2018(8):203-212.
Sheng J, Yang Y, Cui Y, et al. M2 macrophage-mediated interleukin-4 signalling induces myofibroblast phenotype during the progression of benign prostatic hyperplasia[J].Cell Death Dis,2018,9(7):755.
Kim HJ, Jin BR, An HJ. Hesperidin ameliorates benign prostatic hyperplasia by attenuating cell proliferation, inflammatory response, and epithelial-mesenchymal transition via the TGF-β1/Smad signaling pathway[J].Biomed Pharmacother,2023 (4):114389.
Luo W, Xu Q, Wang Q, et al. Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease[J].Sci Rep,2017(7):44612.
Gao S, Zhou J, Liu N, et al. Curcumin induces M2 macrophage polarization by secretion IL-4 and/or IL-13[J].Mol Cell Cardiol,2015(8):131-139.
Almukadi H, Eid BG, Shaik RA, et al. Auraptene nanoparticles ameliorate testosterone-induced benign prostatic hyperplasia in rats: Emphasis on antioxidant, anti-inflammatory, proapoptotic and PPARs activation effects[J].Biomed Pharmacother,2021 (11):112199.
Essandoh K, Li Y, Huo J, et al. MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response[J].Shock,2016,46(2):122-131.
Liu L, Wan Y, Shen A, et al. miRNA Regulation Network Analysis in Qianliening Capsule Treatment of Benign Prostatic Hyperplasia[J].Evid Based Complement Alternat Med, 2015*7):365484.
Viana NI, Reis ST, Dip NG, et al. MicroRNAs 143 and 145 may be involved in benign prostatic hyperplasia pathogenesis through regulation of target genes and proteins[J].Int J Biol Markers,2014,29(3):246-252.
Jin BR, An HJ. Oral administration of berberine represses macrophage activation-associated benign prostatic hyperplasia: a pivotal involvement of the NF-κB[J].Aging (Albany NY),2021,13(16):20016-20028.
Delongchamps NB, de la Roza G, Chandan V, et al. Evaluation of prostatitis in autopsied prostates--is chronic inflammation more associated with benign prostatic hyperplasia or cancer?[J].Urol,2008 May;179(5):1736-1740.
Robert G, Descazeaud A, Nicolaïew N, et al. Inflammation in benign prostatic hyperplasia: a 282 patients’ immunohistochemical analysis[J].Prostate,2009,69(16):1774-1780.
Sheng J, Yang Y, Cui Y, et al. M2 macrophage-mediated interleukin-4 signalling induces myofibroblast phenotype during the progression of benign prostatic hyperplasia[J].Cell Death Dis,2018,9(7):755.
DOI: http://dx.doi.org/10.12345/yzlcyxzz.v6i9.13811
Refbacks
- 当前没有refback。
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。